{"DataElement":{"publicId":"3192225","version":"1","preferredName":"Umbilical Cord Blood Cryoprotective Agent Type","preferredDefinition":"A description of the umbilical cord blood cryoprotective agent.","longName":"3192187v1.0:3192056v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3192187","version":"1","preferredName":"Umbilical Cord Blood Cryoprotective Agent","preferredDefinition":"Blood from the umbilical cord of a newborn baby. This blood contains high concentrations of stem cells (cells from which all blood cells develop)._A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming. [Manually curated]","longName":"2785788v1.0:2512791v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2785788","version":"1","preferredName":"Umbilical Cord Blood","preferredDefinition":"Blood present in the umbilical vessels at the time of delivery. If cryopreserved at birth, cord blood can serve as a source of autologous lymphocytes for transplantation to a patient later diagnosed and treated for leukemia or lymphoma.","longName":"C13300","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Umbilical Cord Blood","conceptCode":"C13300","definition":"Blood present in the umbilical vessels at the time of delivery. If cryopreserved at birth, cord blood can serve as a source of hematopoietic progenitor cells for transplantation to a patient later diagnosed and treated for a hematopoietic disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"571D1EAA-7088-275E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-17","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2008-09-17","modifiedBy":"ONEDATA","dateModified":"2008-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2512791","version":"1","preferredName":"Cryoprotective Agent","preferredDefinition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.","longName":"C53306","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryoprotective Agent","conceptCode":"C53306","definition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8A7D2B-4894-3081-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2230266","version":"1","preferredName":"Tissue Banking","preferredDefinition":"Concepts linked to Tissue Banking and Pathology activities","longName":"TISSUE BANKING","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F78BDEC8-6723-436F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"REEVESD","dateModified":"2005-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C672BF2-8E7F-56AC-E040-BB89AD434852","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3192056","version":"1","preferredName":"Cryoprotective Agent Type","preferredDefinition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming._Type; a subdivision of a particular kind of thing.","longName":"3192056v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other cryoprotectant","valueDescription":"Other Cryoprotective Agent","ValueMeaning":{"publicId":"3192057","version":"1","preferredName":"Other Cryoprotective Agent","longName":"3192057","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cryoprotective Agent","conceptCode":"C53306","definition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C56C67B-198D-1E23-E040-BB89AD437E85","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C56C67B-19A6-1E23-E040-BB89AD437E85","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA","dateModified":"2011-02-15","deletedIndicator":"No"},{"value":"Glycerol","valueDescription":"Glycerin","ValueMeaning":{"publicId":"3192058","version":"1","preferredName":"Glycerin","longName":"3192058","preferredDefinition":"A trihydroxyalcohol with localized osmotic diuretic and laxative effects. Glycerin elevates the blood plasma osmolality thereby extracting water from tissues into interstitial fluid and plasma. This agent also prevents water reabsorption in the proximal tubule in the kidney leading to an increase in water and sodium excretion and a reduction in blood volume. Administered rectally, glycerin exerts a hyperosmotic laxative effect by attracting water into the rectum, thereby relieving constipation. In addition, glycerin is used as a solvent, humectant and vehicle in various pharmaceutical preparations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycerin","conceptCode":"C29077","definition":"A trihydroxyalcohol with localized osmotic diuretic and laxative effects. Glycerin elevates the blood plasma osmolality thereby extracting water from tissues into interstitial fluid and plasma. This agent also prevents water reabsorption in the proximal tubule in the kidney leading to an increase in water and sodium excretion and a reduction in blood volume. Administered rectally, glycerin exerts a hyperosmotic laxative effect by attracting water into the rectum, thereby relieving constipation. In addition, glycerin is used as a solvent, humectant and vehicle in various pharmaceutical preparations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C56C67B-19B0-1E23-E040-BB89AD437E85","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C56C67B-19C9-1E23-E040-BB89AD437E85","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA","dateModified":"2011-02-15","deletedIndicator":"No"},{"value":"Dimethyl sulfoxide","valueDescription":"Dimethyl Sulfoxide","ValueMeaning":{"publicId":"3192059","version":"1","preferredName":"Dimethyl Sulfoxide","longName":"3192059","preferredDefinition":"A highly polar organic liquid that is used widely as a chemical solvent and a free radical scavenger. It shows a range of pharmacological activity including analgesia and anti-inflammation. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect cells and tissue during cryopreservation and has been used to treat extravasation damage caused by anthracycline-based chemotherapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dimethyl Sulfoxide","conceptCode":"C437","definition":"A highly polar organic liquid that is used widely as a chemical solvent and a free radical scavenger. It shows a range of pharmacological activity including analgesia and anti-inflammation. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect cells and tissue during cryopreservation and has been used to treat extravasation damage caused by anthracycline-based chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C56C67B-19D5-1E23-E040-BB89AD437E85","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C56C67B-19EE-1E23-E040-BB89AD437E85","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA","dateModified":"2011-02-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3192055","version":"1","preferredName":"Cryoprotective Agent Type","preferredDefinition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.:Type; a subdivision of a particular kind of thing.","longName":"C53306:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryoprotective Agent","conceptCode":"C53306","definition":"A substance that is used to protect from the effects of freezing, largely by preventing large ice crystals from forming.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C56C67B-1963-1E23-E040-BB89AD437E85","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"ONEDATA","dateModified":"2011-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C56C67B-1974-1E23-E040-BB89AD437E85","latestVersionIndicator":"Yes","beginDate":"2011-02-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-15","modifiedBy":"KUMMEROA","dateModified":"2012-04-23","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3191905","version":"1","longName":"2007r1:Cord Blood Unit -SCTOD Data Requirements","context":"NHLBI"}]}],"AlternateNames":[{"name":"cbu_cryoprotectant","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Cryoprotectant used:","type":"Preferred Question Text","description":"Cryoprotectant used:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C68B4E7-0D77-6B88-E040-BB89AD430EE9","latestVersionIndicator":"Yes","beginDate":"2011-02-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-02-16","modifiedBy":"KUMMEROA","dateModified":"2021-06-16","changeDescription":". 2021-6-16 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}